National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$49.95
add to cart

Rights & Permissions

topleft topright

Kidney Failure and the Federal Government (1991)
Institute of Medicine (IOM)

Citation Manager

. "Appendix D: Survival Analysis Methods for the End-Stage Renal Disease (ESRD) Program of Medicare." Kidney Failure and the Federal Government. Washington, DC: The National Academies Press, 1991.

Please select a format:

BibTeX EndNote RefMan


Page
400
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Kidney Failure and the Federal Government

Held PJ, et al. 1990. Five-year survival for end stage renal disease patients in the U.S., Europe, and Japan, Am J Kid Dis 15:451–457.

Kalbfleisch JD, Prentice RL. 1980. The Statistical Analysis of Failure Time Data, New York, Wiley.


Lawless JF. 1982. Statistical Models and Methods for Lifetime Data, New York, Wiley.


Payne CD. 1987. The GLIM System Release 3.77, Royal Statistical Society, NAG, Downers Grove, IL.

Port FK, Wolfe RA, Hawthorne VM, Ferguson CW. 1989. Discontinuation of dialysis therapy as a cause of death, Am J Nephrol 9:145–149.


SAS Institute. 1988. SAS/STAT User's Guide, Release 6.03, SAS Institute Inc, Cary, NC.


USRDS (U.S. Renal Data System). 1989. Annual Data Report. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.

USRDS. 1990. Annual Data Report. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.


Vaupel JW, et al. 1985. Heterogeneity's ruses: Some surprising effects of selection on population dynamics, Am Statist 39:176–185.


Wolfe RA, Port FK, Hawthorne WM, Guire, KE. 1990. A comparison of survival among dialytic therapies of choice: In-center hemodialysis versus continuous ambulatory peritoneal dialysis at home. Am J Kidney Dis 15:433–440.

Page
400
Front Matter (R1-R14)
Part I: Overview, Summary (1-22)
Introduction (23-36)
Part II: Patients and Providers, Perspectives of ESRD Patients (37-50)
Ethical Issues (51-61)
The Patient Population (62-84)
The ESRD Patient Population: Special Groups (85-109)
Structure of the Provider Community (110-132)
Part III: Access, Access Problems of ESRD Patients (133-166)
Access to Kidney Transplantation (167-188)
Part IV: Reimbursement and Quality, Medicare ESRD Payment Policy (189-211)
Reimbusement Effects on Quality (212-235)
Outpatient Dialysis Reimbursement Issues (236-273)
Quality Assessment and Assurance (274-312)
Part V: Data and Research, Data Systems (313-327)
Research Needs (328-334)
Appendix A: Glossary (335-346)
Appendix B: Acronyms and Initialisms (347-350)
Appendix C: Commissioned Papers and Contractor Reports (351-352)
Appendix D: Survival Analysis Methods for the End-Stage Renal Disease (ESRD) Program of Medicare (353-400)
Appendix E: Institute of Medicine ESRD Study Committee Public Hearing, May 5, 1989, Chicago, Illinois (401-402)
Appendix F: Institute of Medicine ESRD Study Committee Public Hearing on (403-404)
Appendix G: Institute of Medicine ESRD Study Committee Workshop on ESRD Staffing, November 3, 1989, Washington, D.C. (405-405)
Appendix H: Institute of Medicine ESRD Study Committee Workshop on Kidney Transplantation, December 13, 1989, Washington, D.C. (406-407)
Appendix I: Institute of Medicine ESRD Study Committee Workshop on Black and Other Nonwhite ESRD Patients, May 15, 1990, Washington, D.C. (408-408)
Appendix J: Institute of Medicine ESRD Study Committee ESRD Patient Focus-Group Participants (409-410)
Index (411-426)